Skip to main content

Molecular and cellular biology of basal cell carcinoma

Buy Article:

$51.00 plus tax (Refund Policy)



The finding of mutations in the PTCH gene in both Gorlin's syndrome and sporadic basal cell carcinomas has significantly advanced our understanding of the molecular defects that lead to the formation of these tumours. Knowledge of the specific molecular and functional changes that have taken place in these tumours will help us devise more defined therapies, as well as give us a better understanding of normal molecular pathways involved in skin development and function. The following is a summary of our current understanding of the molecular and cellular biology of basal cell carcinoma.

Keywords: Bcl-2; Patched; TGF-β; apoptosis; p53

Document Type: Research Article


Affiliations: 1: Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia 2: Centre for Immunology and Cancer Research, Princess Alexandra Hospital, Brisbane, Australia

Publication date: 2002-11-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more